期刊文献+

ADAM17-siRNA抑制人MCF-7乳腺癌细胞体外侵袭能力的研究 被引量:11

Inhibitory Effects of ADAM17-siRNA on the Invasion of Human MCF-7 Breast Cancer
下载PDF
导出
摘要 目的:观察人MCF-7乳腺癌细胞中解聚素-金属蛋白酶17(ADAM17)的表达受抑制后对肿瘤细胞体外侵袭能力的影响。方法:构建可以表达针对ADAM17的小干扰RNA(siRNA)的干涉载体,转染人乳腺癌细胞系MCF-7。利用real-time PCR法检测肿瘤细胞内ADAM17 mRNA的表达水平,Western blot法检测ADAM17蛋白的表达,Transwell方法检测肿瘤细胞的体外侵袭能力。结果:ADAM17 mRNA及蛋白在MCF-7细胞中呈高表达,转染特异性ADAM17-siRNA后,其表达显著被抑制,同时细胞的体外侵袭能力也明显受到抑制。结论:ADAM17及特异性的siRNA有望成为抗肿瘤侵袭治疗的新方法。 Objective:To investigate the effect of a disintegrin and metalloproteinase 17 (ADAM17)-siRNA on the invasion of human MCF-7 breast cancer cells.Methods:ADAM17-siRNA was transfected into MCF-7 breast cancer cells mediated by oligofectamine.ADAM17 mRNA and protein expressions were detected by real-time PCR and Western blot respectively,and the invasive ability of MCF-7 cells was studied by Transwell method.Results:ADAM17 mRNA and protein showed higher expression in MCF-7 cells,while it was significantly decreased with ADAM17 siRNA treatment.Furthermore,the invasive ability of MCF-7 cells was markedly inhibited by ADAM17 siRNA.Conclusion:ADAM17 plays an important role in the invasion of MCF-7 breast cancer cells,and ADAM17-siRNA can inhibit the invasive ability of MCF-7 cells by blocking the expression of ADAM17.
出处 《天津医药》 CAS 北大核心 2011年第11期1045-1047,共3页 Tianjin Medical Journal
基金 河北省自然科学基金资助项目(项目编号:C2010001767)
关键词 乳腺肿瘤 金属蛋白酶类 RNA 小分子干扰 肿瘤侵润 转染 聚合酶链反应 印迹法 蛋白质 breast neoplasms metalloproteases RNA small interfering neoplasm invasiveness transfection polymerase chain reaction blotting Western
  • 相关文献

参考文献6

二级参考文献63

  • 1张惠卿,张宇新,张作凤,刘志忠,周洪霞,张国志.γ-synuclein在乳腺癌中的表达及意义[J].中国肿瘤临床,2005,32(1):9-12. 被引量:8
  • 2赵晶,赵广才,刘君,方志沂.c-erbB-2在乳腺癌中的表达及其15年远期临床意义分析[J].肿瘤防治研究,2005,32(3):187-188. 被引量:11
  • 3丁翔,杨连粤,黄耿文,王伟,鲁伟群.ADAM17 mRNA在孤立性大肝癌中的表达及其意义[J].中华肝胆外科杂志,2005,11(8):544-546. 被引量:18
  • 4Cheng X, Hung MC. Breast cancer brain metastases [ J ]. Cancer Metastasis Rev,2007,26(3 -4) :635 -643.
  • 5Kazuki Nabeshima, Teruhiko Inoue, Yoshiya Shimao, et al. Matrix metalloproteinases in tumor invasion: Role for cell migration [ J ]. Pathol Intern ,2002,52:255 - 264.
  • 6E Mylona,A Kapranou, J Mavrommtis, et al. The multifunctional role of the immunohistochemical expression of MMP - 7 in invasive breast cancer[ J]. APMIS ,2005,113:246 - 55.
  • 7Sliwowska I, Kopczynski Z. Zymog - raphy - method for quantitation of activity on gelatinase A (pro -MMP -2,72 kDa) and gelatinase B ( pro - MMP - 9,92 kDa) in serum of patients with breast cancer[J]. Wiad Lek,2007,60(5 -6):241 -247.
  • 8L Nakopoulou, I Giannopoulou,A Ch Lazaris, et al. The favorable prognostic impact of tissue inhibitor of matrixme - talloproteinases -1 protein over expression in breast cancer cells [ J ]. APMIS, 2003,111:1027 - 1036.
  • 9Kargozaran H,Yuan SY,Breslin JW,et al. A role for endothelial - derived matrix metalloproteinase - 2 in breast cancer cell transmigration across the endothe - lial -basement membrane barrier[ J]. Clin Exp Metastasis, 2007,24 ( 7 ) :495 - 502.
  • 10Chandru H, Sharada AC, Manjunath S. Expression of matrix metalloproteinase ( MMP - 2) and extracellular matrix meta - lloproteinases inducer (EMMPRIN) in be - nign and advanced breast cancer tissue samples [ J]. Biomed Khim ,2007,53 (4) :461 - 467.

共引文献44

同被引文献132

  • 1王苹苹,孔繁平,陈学群,杜继曾.低氧细胞应激的HIF-1信号通路[J].浙江大学学报(医学版),2011,40(5):559-566. 被引量:74
  • 2丁翔,杨连粤,黄耿文,王伟,鲁伟群.ADAM17 mRNA在孤立性大肝癌中的表达及其意义[J].中华肝胆外科杂志,2005,11(8):544-546. 被引量:18
  • 3Carl-McGrath S, Lendeckel U, Ebert M, et al. The disintegrin- metalloproteinases ADAM9,ADAM12, and ADAM15 are upregula- ted in gastric cancer[J]. International journal of ontology,2005,26(1): 17-24.
  • 4Moss ML, Jin SL, Milla ME, et al. Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor- alpha[J].Nature,385( 1997)733 -736.
  • 5McGowan PM, Ryan BM, Hill AD, et al. ADAM-17 expression inbreast cancer correlates with vamablesof tumor progression[J]. Clin Cancer Res,2007,13(8):2335-2343.
  • 6Sinnathamby G, Zerfass J, Harrier J, et al. ADAM metallopeptidase domain 17 (ADAM17) is naturally processed through major histocompatibility complex (MHC) class I molecules and is a potential immunotherapeutic target in breast, ovarian and prostate cancers[J]. ClinExplmmunol,2011,163:324-332.
  • 7BorreU-Pages M, Rojo F, Albanell J, et al. TACE is required for the activation of the EGFB by TGF-alpha in tumors[J]. Embo J,2003,22(5 ):1114-1124.
  • 8Kermy PA, Bissell MJ. Targeting TACE-dependent EGFR ligand shedding in breast cancer[J]. Journal of Clinical Investigation,2007,11 7(2):337-345.
  • 9Tanaka Y, Miyamoto S, Suzuki SO, et al. Clinical significance of hepurin-binding epidermal growth factor-like growth factor and a disintegrin and metalloprotease 17 expression in human ovarian cancer[J]. Clin Cancer Res,2005,11(13):4783-4792.
  • 10Mumm JS, Schroeter Eh, Saxena MT, et al. Aliqand-induced extracellular cleavage regulate gamma-secretase-like proteo-lytic activation of notch[J]. Mol Cell,2000,5(2):197-206.

引证文献11

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部